March 2011

Like the Deep South Network for Cancer Control, the Sowing the Seeds of Health program relies on community health advisors to spread the word about cancer prevention and early detection

New research suggested that concern about pain may deter obese women from undergoing mammography, while a busy schedule may dissuade women aged less than 60 years

New data suggest that office-based injection laryngoplasty (IL) appears to be a safe and effective treatment for laryngeal dysfunction in cancer patients.

New data suggest that a diagnosis of cancer does not necessarily lead to depression.

New data suggest that immigration status may help explain why some women decide to be screened for cervical cancer and others do not

According to a retrospective review of a SEER-Medicare database presented at the ASCO Genitourinary Cancers Symposium

Performing robotic-assisted laparoscopic radical prostatectomy (RALP) surgeries at an expert level is not as easy as has been previously assumed

According to primary results of a phase III randomized, placebocontrolled trial reported at the 2011 ASCO Genitourinary Cancers Symposium

A subgroup analysis of a randomized trial showed that patients with previously treated metastatic renal cell carcinoma had significant improvement in progression-free survival when they received everolimus.

Dutasteride, a drug commonly used to treat benign prostatic hyperplasia, may also be useful as part of a "watchful waiting" strategy

cabozantinib (XL184) - a novel wide-spectrum tyrosine kinase inhibitor (TKI) - achieved dramatic results in patients with castration-resistant prostate cancer

FDA updates for the Month of March

Though taking multivitamins has been linked to potential health benefits, a new study has found that an excessive consumption of multivitamins may not be beneficial.

CYP2D6 phenotype status does not predict tamoxifen efficacy in patients with early-stage breast cancer, according to a retrospective analysis of data from the Breast International Group

Breast cancer researcher Edith A. Perez, MD, is aiming to present more detailed study findings at national conferences later this year that will help clinicians better identify patients who would benefit from HER2 targeted treatment.

The John Theurer Cancer Center is proud to be partnering with Intellisphere to advance this mission by overseeing editorial content development and helping to provide in-depth content, new learning opportunities, and bestpractice approaches to cancer care.

Recent reports published in the Childhood Cancer Survivor Study (CCSS) are examining the longterm or delayed health effects of cancer treatments.

New research has shown that adding prompt palliative supportive care to standard treatment may not only improve mood and quality of life in cancer patients, but it may even extend survival.

The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care

Amid advances in gene-based cancer diagnostics, questions about the best use of molecular and cellular assays in practice are growing along with the new options for clinicians.